Bond Screener
Mylan NV
LEI 549300A0CD4KNFGIIS89
Liquidated
Successor company:
Mylan II B.V.
Organization name
Mylan NV
Country name
Netherlands
Country of registration
Netherlands
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Mylan NV is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
|
General information
-
Organization nameMylan NV
-
Organization statusLiquidated
-
AddressBuilding 4 Trident Place Mosquito Way Hatfield, United Kingdom, AL10 9UL
IFRS/US GAAP reports
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
Show all
Hide
Authorization required
You need to request access
Affiliates
Stocks
General information
-
Organization nameMylan NV
-
Organization statusLiquidated
-
AddressBuilding 4 Trident Place Mosquito Way Hatfield, United Kingdom, AL10 9UL
Codes
-
LEI549300A0CD4KNFGIIS89
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
CIK0001623613
